Insider Acquisitions in Phase Holographic Imaging

CEO Patrik Eschricht, chairman Peter Egelberg and deputy board member Ann Christine Egelberg has recently acquired additional holdings in Phase Holographic Imaging.

Respectively on April 19 and April 21, 2023, Patrik Eschricht acquired shares totaling 206 472 SEK and acquired 1 250 TO 3 warrants that will be subscribed for a value of 4 725 SEK.

After recently acquiring additional TO 3 warrants on April 21, 2023, Peter and Ann Christine Egelberg subscribed to all TO 3 warrants held privately and by fully owned companies for a total of 121 856 SEK on April 24, 2023.

For additional information, please contact:
Lisa Bodily
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.